Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Emerging Electronic Tools in Cardiovascular Outcomes Studies

Session Chair(s)

Jonathan  Plehn, DrMed, FACC

Jonathan Plehn, DrMed, FACC

Vice President, Global Therapeutic Lead, Cardiovascular/Metabolic Unit

Covance Inc., United States

The costs of performing large cardiovascular outcomes trials is prohibitive and constraining to development of new molecular entities. We will describe novel electronic techniques that can add to trial rigor and efficiency while reducing costs.

Learning Objective : Identify challenges specific to large outcomes trials that can be addressed with novel electronic, web-based approaches; Describe the operation of electronic systems that add efficiency and reduce costs in large outcomes trials.

Speaker(s)

Steffan  Ekman, MPharm, MSc, RPh

CV Endpoint Management: From Identification to Adjudication

Steffan Ekman, MPharm, MSc, RPh

F. Hoffmann-La Roche AG , Switzerland

Senior Clinical Scientist

Judith  Teall, RN

Mobile Patient Engagement in Cardiovascular Outcomes: A Two Way Process

Judith Teall, RN

Independent Consultant, United Kingdom

Rob  Saiter, MS

Applications and Efficiencies of Research Portals in Cardiovascular Outcomes Trials

Rob Saiter, MS

Accenture, United States

Managing Director, Life Sciences R&D

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.